Gossamer Bio announced a 1-for-80 reverse stock split to regain Nasdaq listing compliance. The split became effective on September 11, reducing the authorized share count to 50 million.
Gossamer Bio announced a 1-for-80 reverse stock split to regain Nasdaq listing compliance. The split became effective on September 11, reducing the authorized share count to 50 million.